Kiromic BioPharma Statistics Share Statistics Kiromic BioPharma has 2.65M
shares outstanding. The number of shares has increased by 72.03%
in one year.
Shares Outstanding 2.65M Shares Change (YoY) 72.03% Shares Change (QoQ) 71.64% Owned by Institutions (%) 4.93% Shares Floating 1.18M Failed to Deliver (FTD) Shares 659 FTD / Avg. Volume 8.55%
Short Selling Information The latest short interest is 45.74K, so undefined% of the outstanding
shares have been sold short.
Short Interest 45.74K Short % of Shares Out n/a Short % of Float 4.09% Short Ratio (days to cover) 1.45
Valuation Ratios The PE ratio is -0.87 and the forward
PE ratio is -0.52.
Kiromic BioPharma's PEG ratio is
0.01.
PE Ratio -0.87 Forward PE -0.52 PS Ratio 0 Forward PS n/a PB Ratio -1.86 P/FCF Ratio -1.18 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Kiromic BioPharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.16,
with a Debt / Equity ratio of -1.16.
Current Ratio 0.16 Quick Ratio 0.16 Debt / Equity -1.16 Debt / EBITDA -0.61 Debt / FCF -0.73 Interest Coverage 6.39
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-611.32K Employee Count 44 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -93.53% in the
last 52 weeks. The beta is 1.66, so Kiromic BioPharma's
price volatility has been higher than the market average.
Beta 1.66 52-Week Price Change -93.53% 50-Day Moving Average 1.06 200-Day Moving Average 1.37 Relative Strength Index (RSI) 24.45 Average Volume (20 Days) 7,709
Income Statement
Revenue n/a Gross Profit n/a Operating Income -23.77M Net Income -26.9M EBITDA -23.77M EBIT -30.62M Earnings Per Share (EPS) -1.03
Full Income Statement Balance Sheet The company has 1.14M in cash and 14.57M in
debt, giving a net cash position of -13.43M.
Cash & Cash Equivalents 1.14M Total Debt 14.57M Net Cash -13.43M Retained Earnings -149.79M Total Assets 8.54M Working Capital -17.6M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -19.46M
and capital expenditures -366K, giving a free cash flow of -19.82M.
Operating Cash Flow -19.46M Capital Expenditures -366K Free Cash Flow -19.82M FCF Per Share -0.76
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields KRBP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for KRBP.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 13, 2023. It was a
backward
split with a ratio of 1:30.
Last Split Date Mar 13, 2023 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -35.95 Piotroski F-Score 2
